- Trials with a EudraCT protocol (892)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (4)
892 result(s) found for: Deterioration.
Displaying page 1 of 45.
EudraCT Number: 2014-003596-27 | Sponsor Protocol Number: BIBABRAX | Start Date*: 2015-02-23 | |||||||||||
Sponsor Name:Asociación de Oncología Médica del Hospital de Cruces (ASONMEC) | |||||||||||||
Full Title: A Phase II Study of Nab-paclitaxel and Gemcitabine, in Elderly Patients with Previously Untreated, Metastatic Pancreatic Adenocarcinoma | |||||||||||||
Medical condition: Metastatic pancreatic cancer | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004101-75 | Sponsor Protocol Number: S56122-ML10190 | Start Date*: 2014-03-28 | ||||||||||||||||
Sponsor Name:UZ Leuven | ||||||||||||||||||
Full Title: Randomized crossover trial to assess the effects and quality of life in patients with locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel: Q... | ||||||||||||||||||
Medical condition: locally advanced or metastatic pancreatic cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-002345-42 | Sponsor Protocol Number: 998 | Start Date*: 2020-08-26 | |||||||||||
Sponsor Name:Biotest AG | |||||||||||||
Full Title: A randomized, placebo controlled, double-blind, multi-center, phase II trial investigating the efficacy and safety of trimodulin (BT588) as add-on therapy to standard of care in adult subjects with... | |||||||||||||
Medical condition: Severe Corona Virus Disease 2019 (COVID-19) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000617-43 | Sponsor Protocol Number: CLEE011F2301 | Start Date*: 2015-05-27 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: MONALEESA-3: A randomized double-blind, placebo-controlled study of ribociclib in combination with fulvestrant for the treatment of men and postmenopausal women with hormone receptor positive, HER2... | |||||||||||||
Medical condition: men and postmenopausal women with HR+, HER2-negative advanced (loco regionally recurrent not amenable to curative therapy or metastatic) breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DE (Completed) AT (Completed) ES (Completed) CZ (Completed) DK (Completed) NL (Completed) HU (Completed) BE (Completed) BG (Completed) FR (Completed) PT (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001166-26 | Sponsor Protocol Number: M13-813 | Start Date*: 2015-12-28 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Randomized, Placebo Controlled Phase 3 Study of ABT-414 with Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects with Newly Diagnosed Glioblastoma (GBM) with Epidermal Growth Factor R... | |||||||||||||
Medical condition: Newly diagnosed glioblastoma (GBM) or gliosarcoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) NL (Completed) IE (Completed) DE (Completed) BE (Completed) AT (Completed) GB (GB - no longer in EU/EEA) PT (Completed) ES (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000119-66 | Sponsor Protocol Number: BO41843 | Start Date*: 2020-11-06 | ||||||||||||||||||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | ||||||||||||||||||||||||||||
Full Title: A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF GDC-9545 COMBINED WITH PALBOCICLIB COMPARED WITH LETROZOLE COMBINED WITH PALBOCICLI... | ||||||||||||||||||||||||||||
Medical condition: First line of treatment for Estrogen receptor (ER)-positive, HER2-negative locally advanced or metastatic breast cancer | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: HU (Trial now transitioned) DE (Trial now transitioned) PL (Trial now transitioned) GB (GB - no longer in EU/EEA) FR (Trial now transitioned) AT (Trial now transitioned) PT (Trial now transitioned) DK (Trial now transitioned) BE (Trial now transitioned) IT (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002031-24 | Sponsor Protocol Number: HAM005 | Start Date*: 2006-06-14 |
Sponsor Name:Imperial College | ||
Full Title: The HAM Ciclosporin Study: An observational trial of therapy in early or progressing HAM/TSP | ||
Medical condition: HTLV-I-associated myelopathy | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-023184-18 | Sponsor Protocol Number: C10-44 | Start Date*: 2012-01-25 | |||||||||||
Sponsor Name:Inserm | |||||||||||||
Full Title: PRE clinical mutation CARriers from families with DIlated cardiomyopathy and ACE inhibitors (PRECARDIA-INHERITANCE study) Preventive effect of ACE inhibitor (perindopril) on the onset or progres... | |||||||||||||
Medical condition: dilated cardiomyopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001540-23 | Sponsor Protocol Number: 309560 | Start Date*: 2006-03-03 |
Sponsor Name:Schering Nordiska AB | ||
Full Title: A Scandinavian, randomized, rater-blinded study of single and double-dose (2x250 mcg e.o.d.) Betaferon in patients with early secondary progressive multiple sclerosis. | ||
Medical condition: Early Secondary Progressive Multiple Sclerosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-002513-35 | Sponsor Protocol Number: CRLX030A3301 | Start Date*: 2013-11-28 |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: A multicenter, prospective, randomized, open label study to assess the effect of serelaxin versus standard of care in acute heart failure (AHF) patients. | ||
Medical condition: Acute heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) AT (Prematurely Ended) HU (Prematurely Ended) IT (Prematurely Ended) CZ (Prematurely Ended) SK (Prematurely Ended) BE (Completed) PT (Prematurely Ended) BG (Completed) LT (Completed) PL (Prematurely Ended) LV (Prematurely Ended) EE (Completed) FI (Prematurely Ended) SI (Prematurely Ended) GR (Prematurely Ended) ES (Prematurely Ended) HR (Prematurely Ended) DK (Prematurely Ended) IS (Prematurely Ended) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005859-18 | Sponsor Protocol Number: SC05-03 | Start Date*: 2006-06-13 | |||||||||||
Sponsor Name:FONDAZIONE SANTA LUCIA | |||||||||||||
Full Title: EFFECT OF MEMANTINE TREATMENT ON BRAIN FUNCTION AND MORPHOLOGICAL STRUCTURE IN PATIENTS WITH MODERATE TO SEVERE PATIENTS WITH ALZHEIMER S DISEASE A STRUCTURAL MR AND FMRI STUDY | |||||||||||||
Medical condition: Moderate to severe Alzheimer s disease | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002000-34 | Sponsor Protocol Number: CLOZAPINA-1 | Start Date*: 2007-04-09 |
Sponsor Name:Fundación Cerebro y Mente | ||
Full Title: CLOZAPINA EN PRIMEROS BROTES DE ESQUIZOFRENIA COMO POSIBLE TRATAMIENTO PREVENTIVO DEL DETERIORO CEREBRAL Y CLINICO | ||
Medical condition: Schizophrenia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003084-61 | Sponsor Protocol Number: CLEE011A2301 | Start Date*: 2014-01-24 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A randomized double-blind, placebo-controlled study of LEE011 in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive, HER2-negative, advanced breast ... | |||||||||||||
Medical condition: HR+, HER2- advanced breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: AT (Completed) DE (Completed) CZ (Completed) ES (Completed) SE (Completed) NL (Completed) HU (Completed) FI (Completed) IE (Completed) BE (Completed) DK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002385-74 | Sponsor Protocol Number: BAY59-7939/17618 | Start Date*: 2015-04-24 |
Sponsor Name:Bayer HealthCare AG | ||
Full Title: 7-day study of the safety, efficacy and the pharmacokinetic and pharmacodynamic properties of oral rivaroxaban in children from birth to less than 6 months with catheter-related arterial or venous ... | ||
Medical condition: Catheter related venous or arterial thrombosis | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Completed) AT (Completed) DE (Completed) NL (Completed) PL (Completed) FR (Completed) FI (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-005468-10 | Sponsor Protocol Number: C16011 | Start Date*: 2012-11-28 |
Sponsor Name:Millennium Pharmaceuticals, Inc. | ||
Full Title: A Phase 3 Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment Administered to Patients With Relapsed or Refra... | ||
Medical condition: Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) NL (Completed) GB (Prematurely Ended) IT (Ongoing) GR (Completed) ES (Prematurely Ended) DK (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-003461-35 | Sponsor Protocol Number: 20210096 | Start Date*: 2022-02-22 | ||||||||||||||||
Sponsor Name:Amgen Inc. | ||||||||||||||||||
Full Title: A Randomized, Multi-center, Double-blind, Placebo-controlled Phase 3 Study of Bemarituzumab plus Chemotherapy versus Placebo plus Chemotherapy in Subjects with Previously Untreated Advanced Gastric... | ||||||||||||||||||
Medical condition: Untreated Advanced Gastric or Gastroesophageal Junction Cancer with FGFR2b Overexpression | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Trial now transitioned) LT (Trial now transitioned) LV (Ongoing) HU (Trial now transitioned) DK (Trial now transitioned) BE (Trial now transitioned) ES (Ongoing) IT (Ongoing) SE (Trial now transitioned) BG (Trial now transitioned) PT (Trial now transitioned) PL (Trial now transitioned) NO (Trial now transitioned) IE (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004191-22 | Sponsor Protocol Number: PH001Precycle | Start Date*: 2017-06-20 |
Sponsor Name:Palleos healthcare GmbH | ||
Full Title: PRECYCLE: Multicenter, randomized phase IV intergroup trial to evaluate the impact of e Health-based patient reported outcome (PRO) assessment on quality of life in patients with hormone receptor p... | ||
Medical condition: advanced and or metastatic breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000736-37 | Sponsor Protocol Number: 1001 | Start Date*: 2022-08-12 | ||||||||||||||||
Sponsor Name:Biotest AG | ||||||||||||||||||
Full Title: A randomized, placebo-controlled, double-blind, multi-center, phase III trial to assess the efficacy and safety of trimodulin (BT588) in adult hospitalized subjects with CAP including COVID-19 pneu... | ||||||||||||||||||
Medical condition: non-severe community-acquired pneumonia (CAP) or moderate or severe Coronavirus Disease 2019 (COVID-19) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) ES (Prematurely Ended) HU (Completed) AT (Ongoing) BE (Ongoing) LV (Ongoing) LT (Ongoing) PT (Ongoing) SK (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000608-40 | Sponsor Protocol Number: No-DAPT-TAVI | Start Date*: 2018-07-06 | |||||||||||
Sponsor Name:AOU DI BOLOGNA POLICLINICO S.ORSOLA-MALPIGHI | |||||||||||||
Full Title: Aspirin versus Aspirin plus Clopidogrel in Patients Undergoing Transcatheter Aortic Valve Replacement: a Randomized Multicenter Study | |||||||||||||
Medical condition: valvular aortic stenosis submitted to TAVI | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-004998-32 | Sponsor Protocol Number: ARGX-117-2003 | Start Date*: 2022-09-29 | |||||||||||
Sponsor Name:argenx BV | |||||||||||||
Full Title: A Long-Term Extension of the ARGX-117-2002 Trial to Evaluate the Long-term Safety and Tolerabillity, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults with Mult... | |||||||||||||
Medical condition: Multifocal Motor Neuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) DE (Trial now transitioned) IT (Ongoing) NL (Trial now transitioned) AT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.